Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Larson

Showing results (181-190 of 300) with videos related to

Pageof 30
Sort By:
Cancer Metastasis Reviews|June 14, 2006
Molecular targeting of the lymphovascular system for imaging and therapyHeiko Schöder, Edwin C Glass, Alain P Pecking, et al.
Bioconjugate Chemistry|January 25, 2021
Correction to An <i>N</i>-Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted RadioimmunotherapySarah M Cheal, Mitesh Patel, Guangbin Yang, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 13, 2016
Copper-64 trastuzumab PET imaging: a reproducibility studyJorge A Carrasquillo, Patrick G Morris, John L Humm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trialRobert J Downey, Tim Akhurst, David Ilson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2018
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered LymphocytesSimone Krebs, Afruja Ahad, Lukas M Carter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2004
PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancerPat B Zanzonico, Ronald Finn, Keith S Pentlow, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptideWilliam J McBride, Pat Zanzonico, Robert M Sharkey, et al.
EJNMMI Research|March 7, 2018
I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinomaJorge A Carrasquillo, Joseph A O'Donoghue, Volkan Beylergil, et al.
Cancer|June 15, 2013
Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancerKaren A Autio, Neeta Pandit-Taskar, Jorge A Carrasquillo, et al.
Journal of Medicinal Chemistry|October 25, 2007
Synthesis and biological evaluation of a fluorine-18 derivative of dasatinibDarren R Veach, Mohammad Namavari, Nagavarakishore Pillarsetty, et al.
Pageof 30

Showing results (181-190 of 300) with videos related to

Sort By:
Pageof 30
Cancer Metastasis Reviews|June 14, 2006
Molecular targeting of the lymphovascular system for imaging and therapyHeiko Schöder, Edwin C Glass, Alain P Pecking, et al.
Bioconjugate Chemistry|January 25, 2021
Correction to An <i>N</i>-Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted RadioimmunotherapySarah M Cheal, Mitesh Patel, Guangbin Yang, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 13, 2016
Copper-64 trastuzumab PET imaging: a reproducibility studyJorge A Carrasquillo, Patrick G Morris, John L Humm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trialRobert J Downey, Tim Akhurst, David Ilson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2018
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered LymphocytesSimone Krebs, Afruja Ahad, Lukas M Carter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2004
PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancerPat B Zanzonico, Ronald Finn, Keith S Pentlow, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptideWilliam J McBride, Pat Zanzonico, Robert M Sharkey, et al.
EJNMMI Research|March 7, 2018
I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinomaJorge A Carrasquillo, Joseph A O'Donoghue, Volkan Beylergil, et al.
Cancer|June 15, 2013
Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancerKaren A Autio, Neeta Pandit-Taskar, Jorge A Carrasquillo, et al.
Journal of Medicinal Chemistry|October 25, 2007
Synthesis and biological evaluation of a fluorine-18 derivative of dasatinibDarren R Veach, Mohammad Namavari, Nagavarakishore Pillarsetty, et al.
Pageof 30